Skip to main content
. Author manuscript; available in PMC: 2012 Sep 16.
Published in final edited form as: Cell. 2012 Mar 16;148(6):1110–1122. doi: 10.1016/j.cell.2012.02.031

Figure 2. The promise of reprogramming-based disease models.

Figure 2

iPS cell-based models promote research into disease mechanisms, create a framework for screening possible drug compounds, and provide the opportunity to compare different disease genotypes.